Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalisation for Heart Failure (HF)" in Patients With HF and Prolonged QRS

NCT03280862 is registered in ClinicalTrials.gov with Aarhus University Hospital as lead sponsor.

NCT NCT03280862
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03280862 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Does Targeted LV Lead Positioning Towards Latest Local Electric Activation at CRT Implantation Reduce Incidence of the Combined Endpoint "Death or Non-planned Hospitalisation for Heart Failure (HF)" in Patients With HF and Prolonged QRS
Lead sponsor
Aarhus University Hospital
Phase
Not applicable
Overall status
Completed
Start date
March 20, 2018
Completion date
February 27, 2026
Enrollment
1,000 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

branch block, bundle, heart failure